James Frates

James Frates

Chief Financial OfficeratAmylyx Pharmaceuticals· In proxies 2021–2025

Pay in FY2025-46% from the year before · Amylyx Pharmaceuticals stock +219.6% the same year

James Frates was paid $1.4M in FY2025 (Dec), down 46%. Amylyx Pharmaceuticals stock rose 219.6% that year.

Pay$100 in the stock at the end of FY22 → $33
Pay is from the Summary Compensation Table of each Amylyx Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Amylyx PharmaceuticalsPublic company · 5 yr
    • Chief Financial Officer2021 – Present · 5 yrStock in role +55%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?